Moy R, Maas C, Monheit G, Huber MB; Reloxin Investigational Group. Long-term safety and efficacy of a new botulinum toxin type A in treating glabellar lines. Arch Facial Plast Surg. 2009 Mar-Apr;11(2):77-83.
Monheit GD, Baumann L, Maas C, Rand R, Down R. Efficacy, Safety, and Subject Satisfaction After AbobotulinumtoxinA Treatment for Moderate to Severe Glabellar Lines. Dermatol Surg. 2020 Jan;46(1):61-69.
Rzany B, Dill-Müller D, Grablowitz D, Heckmann M, Caird D; German-Austrian Retrospective Study Group. Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients. Dermatol Surg. 2007 Jan;33(1 Spec No.):S18-25.
Schlessinger J, Dover JS, Joseph J, Monheit G, Nelson DB, Albright CD, Axford-Gatley RA, Cohen JL; Dysport Study Group. Long-term safety of abobotulinumtoxinA for the treatment of glabellar lines: results from a 36-month, multicenter, open-label extension study. Dermatol Surg. 2014 Feb;40(2):176-83.
Kassir R, Kolluru A, Kassir M. Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids. Dermatol Ther (Heidelb). 2013 Dec;3(2):179-89.
Data on file (MA-33939).
Öhrlund A. New Method to Study the Balance of Firmness and Flexibility for HA Fillers. Poster presented at AMWC 2019.
Nikolis A, Enright KM, Lazarova D, Sampalis J. The Role of Clinical Examination in Midface Volume Correction Using Hyaluronic Acid Fillers: Should Patients Be Stratified by Skin Thickness? Aesthet Surg J Open Forum. 2020 Feb 6;2(1):ojaa005.
Lundgren B, Sandkvist U, Bordier N, Gauthier B. Using a New Photo Scale to Compare Product Integration of Different Hyaluronan-Based Fillers After Injection in Human Ex Vivo Skin. J Drugs Dermatol. 2018 Sep 1;17(9):982-986.
Philipp-Dormston WG, Wong C, Schuster B, Larsson MK, Podda M. Evaluating Perceived Naturalness of Facial Expression After Fillers to the Nasolabial Folds and Lower Face With Standardized Video and Photography. Dermatol Surg. 2018 Jun;44(6):826-832.
Solish N, Bertucci V, Percec I, Wagner T, Nogueira A, Mashburn J. Dynamics of Hyaluronic Acid Fillers Formulated to Maintain Natural Facial Expression. J Cosmet Dermatol. 2019;18(3):738–746.
Stein P, Vitavska O, Kind P, Hoppe W, Wieczorek H, Schurer NY. The Biological Basis for Poly-L-Lactic Acid-Induced Augmentation. J Dermatol Sci. 2015; 78:26–33.9.
Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-Arm Study for the Characterization of Human Tissue
Response to Injectable Poly-L-Lactic Acid. Dermatol Surg. 2013;39(6):915–22.
Vleggaar D, Fitzgerald R, Lorenc P. Composition and Mechanism of Action of Poly-L-Lactic Acid in Soft Tissue Augmentation. J Drugs Dermatol. 2014;13(4 suppl): s29–31.
Moyle GJ, Lysakova L, Brown S, Sibtain N, Healy J, Priest C, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004;5(2):82–87.
Distante F, Pagani V, Bonfigli A. Stabilized Hyaluronic Acid of Non-animal Origin for Rejuvenating the Skin of the Upper Arm. Dermatol Surg. 2009;35(S1):389–394.
